Phase III trial of docetaxel (D) and carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
- 30 September 1998
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 21, S31-S32
- https://doi.org/10.1016/s0169-5002(98)90060-5
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: